Northern Trust Corp Legend Biotech Corp Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, Northern Trust Corp holds 284,678 shares of LEGN stock, worth $9.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

284,678

Previous 83,892 239.34%

Holding current value

$9.88 Million

Previous $4.09 Million 126.59%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$32.49 - $50.28 $6.52 Million - $10.1 Million	200,786 Added 239.34%	284,678 $9.26 Million
Q3 2024 Nov 13, 2024	SELL	$43.55 - $59.88 $871 - $1,197	-20 Reduced 0.02%	83,892 $4.09 Million
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $158 - $228	-4 Reduced -0.0%	83,912 $3.72 Million
Q1 2024 May 14, 2024	BUY	$55.06 - $69.99 $79,286 - $100,785	1,440 Added 1.75%	83,916 $4.71 Million
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $3.4 Million - $4.14 Million	-59,421 Reduced 41.88%	82,476 $4.96 Million
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $142,804 - $172,966	-2,261 Reduced 1.57%	141,897 $9.53 Million
Q2 2023 Aug 11, 2023	SELL	$46.28 - $75.01 $1.47 Million - $2.38 Million	-31,759 Reduced 18.05%	144,158 $9.95 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $2.88 Million - $3.8 Million	66,224 Added 60.37%	175,917 $8.48 Million
Q4 2022 Feb 13, 2023	BUY	$38.8 - $55.46 $30,613 - $43,757	789 Added 0.72%	109,693 $5.48 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $211,694 - $316,847	5,549 Added 5.37%	108,904 $4.44 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $55.0 $295,554 - $484,660	8,812 Added 9.32%	103,355 $5.68 Million
Q1 2022 May 13, 2022	BUY	$31.02 - $48.18 $2.93 Million - $4.56 Million	94,543 New	94,543 $3.44 Million

Others Institutions Holding LEGN

# of Institutions

232

Shares Held

86.1M

Call Options Held

260K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.81B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Legend Biotech Corp Transaction History